1. Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study.
- Author
-
Soto CL, Hsu AJ, Lee JH, Dzintars K, Choudhury R, Jenkins TC, McCreary EK, Quartuccio KS, Stohs EJ, Zimmerman M, and Tamma PD
- Subjects
- Adult, Humans, Hospitals, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Carbapenems pharmacology, Carbapenems therapeutic use, Microbial Sensitivity Tests, Drug Combinations, Ceftazidime, Sepsis, Bacteremia drug therapy
- Abstract
In a propensity-score-weighted cohort of 183 adults with carbapenem-resistant Enterobacterales bacteremia at 24 US hospitals, patients receiving short courses of active therapy (7-10 days, median 9 days) experienced similar odds of recurrent bacteremia or death within 30 days as those receiving prolonged courses of active therapy (14-21 days, median 14 days)., Competing Interests: Potential conflicts of interest. E. K. M. reports consulting fees for Advisory Boards from AbbVie, Merck, Shionogi, Cidara, Ferring, Summit, La Jolla, Venatorx, Entasis, LabSimply, and Basilea; participation on DSMB for Wockhardt and on DMBD for A Phase I, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous Ertapenem in Combination with Zidebactam (WCK 6777) in Healthy Adult Subjects; speaking honorarium for UTI symposium at ECCMID 2023 from GlaxoSmithKlein (GSK) and speaking honorarium for COVID-19 symposium at IDWeek 2022; travel support to attend ECCMID 2023 from GSK. E. S. has received grant funding from Merck & Co and bioMérieux, Inc. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed., (© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF